Search

Mark Chad Mcmills

from Athens, OH
Age ~68
Get Report
Also known as:
Mark C Mcmills, Mark C Mcmillis
Phone and address:
13 Joneswood Dr, Shade, OH 45701
(740) 593-6178
Related to:
Melissa J Buckley, 71
Connected to:
Christina A Mcmindes, 59Larry E Mcmindes, 81Teresa D Mcminiment, 68Alexander P Mcminn, 87Anna Mcminn, 71Autumn Mcminn, 32Bonnie L Mcminn, 66Chris Mcminn, 58Crystal L Mcminn, 56Darrell Mcminn, 62

Mark Mcmills Phones & Addresses

  • 13 Joneswood Dr, Athens, OH 45701 (740) 593-6178
  • East Lansing, MI
  • 50 Edith Ave, Los Altos, CA 94022
  • Los Altos Hills, CA
  • Danbury, CT
  • Highland Park, NJ
  • Lansing, MI

Resumes

Resumes

Mark Mcmills Photo 1

Chief Strategy Officer

View page
Location:
13 Joneswood Dr, Athens, OH 45701
Industry:
Research
Work:
Promiliad Biopharma
Chief Strategy Officer
Ohio University
Associate Professor
Education:
Michigan State University 1987 - 1989
Doctorates, Doctor of Philosophy, Chemistry Michigan State University 1984 - 1987
Master of Science, Masters, Chemistry Uc Irvine 1979 - 1984
Bachelors, Bachelor of Science, Chemistry Columbia University In the City of New York
Mark Mcmills Photo 2

Mark Mcmills

View page

Publications

Us Patents

Imidazole And Thiazole Compositions For Modifying Biological Signaling

View page
US Patent:
20180362521, Dec 20, 2018
Filed:
May 9, 2018
Appl. No.:
15/975321
Inventors:
- Athens OH, US
Stephen C. Bergmeier - Athens OH, US
Mark C. McMills - Athens OH, US
Cina M. Orac - Athens OH, US
Assignee:
Ohio University - Athens OH
International Classification:
C07D 417/14
C07D 277/36
C07D 417/04
A61K 31/155
A61K 31/427
C07D 413/04
C07D 277/84
C07D 233/84
C07D 417/06
A61K 45/06
C07D 277/16
A61K 31/4166
C07D 405/04
A61K 31/4439
A61K 31/428
Abstract:
Compounds having General Formula (I) or General Formula (II):in which Ris chosen from Cto Caliphatic or heteroaliphatic groups, optionally substituted with one or more aryl groups, substituted aryl groups, heteroaryl groups, substituted heteroaryl groups, or combination thereof; Ris chosen from aromatic moieties, substituted aromatic moieties, heteroaromatic moieties, substituted heteroaromatic moieties, and coumarin; Ris chosen from —H, Cto Caliphatic or heteroaliphatic groups, phenyl, or substituted phenyl, wherein the aliphatic or heteroaliphatic groups are optionally substituted with one or more phenyl groups, aryl groups, heteroaryl groups, substituted heteroaryl groups, or combination thereof, and wherein the aliphatic or heteroaliphatic groups are optionally bonded to Rto form a ring; X is S or O; and Y is S or NH, may be used in pharmaceutical compositions that modify of biological signaling processes or as reagents for biological assays.

Imidazole And Thiazole Compositions For Modifying Biological Signaling

View page
US Patent:
20170210737, Jul 27, 2017
Filed:
May 6, 2015
Appl. No.:
15/326821
Inventors:
- Athens OH, US
Stephen C. Bergmeier - Athens OH, US
Mark C. McMills - Athens OH, US
Crina M. Orac - Athens OH, US
Assignee:
Ohio University - Athens OH
International Classification:
C07D 417/14
C07D 413/04
C07D 405/04
C07D 417/04
C07D 417/06
C07D 277/36
C07D 277/84
C07D 233/84
C07D 277/16
Abstract:
Compounds having General Formula (I) or General Formula (II): in which Ris chosen from Cto Caliphatic or heteroaliphatic groups, optionally substituted with one or more aryl groups, substituted aryl groups, heteroaryl groups, substituted heteroaryl groups, or combination thereof; Ris chosen from aromatic moieties, substituted aromatic moieties, heteroaromatic moieties substituted heteroaromatic moieties, and coumarin; Ris chosen from —H, Cto Caliphatic or heteroaliphatic groups, phenyl, or substituted phenyl, wherein the aliphatic or heteroaliphatic groups are optionally substituted with one or more phenyl groups, aryl groups, heteroaryl groups, substituted heteroaryl groups, or combination thereof, and wherein the aliphatic or heteroaliphatic groups are optionally bonded to Rto form a ring; X is S or O; and Y is S or NH, may be used in pharmaceutical compositions that modify of biological signaling processes or as reagents for biological assays.
Control profile
Mark Chad Mcmills from Athens, OH, age ~68 Get Report